<DOC>
	<DOCNO>NCT02105597</DOCNO>
	<brief_summary>Background : Diabetes mellitus ( DM ) major cause morbidity mortality worldwide . Long-term glycemic control important prevent delay onset DM related complication . Patients often fail achieve optimal glycemic control pharmacotherapy due non-adherence . With high prevalence smartphone usage locally among developed country , grow interest deliver intervention mobile application . In study , mobile application target improve medication adherence among people Type 2 DM develop evaluate . Aims : This study aim ( ) design smartphone application improve medication adherence ( ii ) evaluate impact clinical outcome , health-related quality life ( HRQoL ) health status among patient Type 2 DM . Hypothesis : The use smartphone application improve medication adherence among patient Type 2 DM , well clinical outcome , HRQoL health status . Methods : This randomize , open-label control trial involve patient Type 2 DM manage Singapore General Hospital . Patients see institution 's Diabetes Centre refer pharmacist-led Medication Therapy Management service eligible participate . Patients intervention group mobile application download onto smartphones , control group receive usual standard care . The primary outcome change self-reported medication adherence , determine use 8-item Morisky Medication Adherence Scale . Secondary outcome include change HbA1c , blood glucose , frequency dose titration , addition removal oral hypoglycemic agent , HRQoL ( measure use Audit Diabetes Dependent Quality Life ) health status ( measure use EuroQol-5D-5L EuroQol Visual Analogue Scale ) . All outcome measure baseline end 6-month study period ( ± 4 week ) . Significance : The development evaluation mobile application improve adherence among patient Type 2 DM Singapore first kind , finding study provide much-needed evidence demonstrate effectiveness intervention .</brief_summary>
	<brief_title>A Smartphone Application Improve Medication Adherence Among People With Type 2 Diabetes Mellitus Singapore</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Existing Type 2 DM manage SGH Diabetes Centre refer pharmacistled MTM service Age≥ 40 year HbA1c≥ 8.0 Suspected nonadherence ( e.g . admit missed dos , HbA1c target despite frequent dose titration , recent DM relate hospitalization/ emergency visit ) Owns iOS smartphone WiFi data plan Unable manage medication ( e.g . take care caregiver , nursing home patient , cognitive impairment ) Unable read comprehend English Physical impairment precludes use smart phone function ( e.g . deform finger joint , amputation )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Medication adherence</keyword>
	<keyword>Compliance</keyword>
	<keyword>Mobile health</keyword>
</DOC>